Not exact matches
In 1993, Poirier and his Montreal - based team co-discovered an important genetic risk factor
involved in the most common form of the disease: a defective gene, called
Apolipoprotein E type 4 (ApoE4), that prevents the normal transport of cholesterol and phospholipids to the brain.
In 1999, he was named an Alexander Hollaender Distinguished Fellow where he identified a novel
apolipoprotein (ApoA5)
involved in human and mouse triglyceride metabolism.
Involved in the initial discovery of apoE as a major
apolipoprotein regulating lipoprotein metabolism, including that apoE is induced by fat / cholesterol feeding in atherogenesis.
The two most striking risk factors appear to be hyperinsulinism and possession of one or two E4 alleles for the
apolipoprotein E gene (ApoE4), which is
involved in lipid processing.